E2F1 and hepatocellular carcinoma: The molecular mechanism shows that E2F1 reversely modulates carnitine palmitoyltransferase 2 (CPT2), an essential enzyme for fatty acid oxidation, the downregulation of which promotes HCC development via acylcarnitine accumulation in a lipid-rich environment [51].